Posted by T A P T A P has taken a position in VLGC on the open market and is not compensated in any way by any company mentioned! All information can not be guaranteed but is believed accurate and is for purpose of research and is not a solicitation to buy any security and doing so will be done at your own risk. For more information on VLGC see other posts on T A P Internet/Biotech message boards & Yahoo News/Profile.
Link: VLGC NEWS
on 7/5/2001, 2:58 pm
On todays news (see link below) TAP has decided VLGC (Nasdaq) is worth taking a look at. ViroLogic now has collaborations with Abbott Laboratories, Agouron Pharmaceuticals, Bristol-Myers Squibb, Chiron Corporation, DuPont Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Merck & Co., Hoffmann-La Roche and Vertex Pharmaceuticals and will use ViroLogic's drug resistance testing technology to evaluate drug activity against HIV strains that are resistant to currently available drugs.
As recommended by the U.S. Food and Drug Administration, biopharmaceutical companies are using HIV resistance testing technology to enhance next-generation HIV drug development. There are 15 approved HIV drugs and another 40 new drugs in the pipeline, all of which will require resistance testing in their development. To date, resistance assays have been applied in the later stages of drug development, which we see as about a $70 million market with attractive growth prospects,'' said Bill Young, ViroLogic's Chairman and Chief Executive Officer. ``However, lead drug targets can be screened for resistance profiles much earlier in the development phase, and assays can also be applied in early stage drug discovery. The market potential here is significantly larger than the late stage application, and the technology exists to immediately implement the assay. Use of our assays in earlier stages could save pharmaceutical companies significant time and money.
ViroLogic expects to grow the pharmaceutical segment of its business by applying its technology and expertise to other serious viral diseases where resistance is a key obstacle to treatment.
Message Thread:
« Back to thread